Cargando…
The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study
BACKGROUND: The efficacy of antipsychotics can be evaluated using the dimensional models of schizophrenic symptoms. The D(2)/D(3)-selective antagonist amisulpride has shown similar efficacy and tolerability to other atypical antipsychotics. The aim of the present study was to determine the efficacy...
Autores principales: | Herrera-Estrella, Miguel, Apiquian, Rogelio, Fresan, Ana, Sanchez-Torres, Isabel |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090597/ https://www.ncbi.nlm.nih.gov/pubmed/15869707 http://dx.doi.org/10.1186/1471-244X-5-22 |
Ejemplares similares
-
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study
por: Liang, Ying, et al.
Publicado: (2016) -
Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
por: Apiquian, Rogelio, et al.
Publicado: (2004) -
Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009) -
EEG ALPHA COHERENCE AND PSYCHOPATHOLOGICAL DIMENSIONS OF SCHIZOPHRENIA
por: John, John P., et al.
Publicado: (2002) -
An open label follow-up study on amisulpride in the add-on treatment of bipolar I patients
por: Carta, Mauro Giovanni, et al.
Publicado: (2006)